世界中医药
文章摘要
引用本文:张美珍1,郝晓晖1,李晓文1,杨亚男1,李艳杰2,刘旭菲1,倪青1.益气活血通络法治疗糖尿病周围神经病变Meta分析[J].世界中医药,2021,(05):.  
益气活血通络法治疗糖尿病周围神经病变Meta分析
Meta-analysis of Enriching Qi,Promoting Blood Circulation and Dredging Meridians Therapy for Diabetic Peripheral Neuropathy Treatment
投稿时间:2021-01-20  
DOI:10.3969/j.issn.1673-7202.2021.05.005
中文关键词:  益气活血通络  糖尿病周围神经病变  随机对照试验  Meta分析  有效率  中医药:神经传导速度  不良反应
English Keywords:Enriching qi,promoting blood circulation and dredging meridians  Diabetic peripheral neuropathy  Randomized controlled trials  Meta-analysis  Efficacy  Traditional Chinese medicine  Nerve conduction velocity  Adverse reactions
基金项目:北京市自然科学基金项目(7182143)——基于糖代谢信号通路和均匀设计的抗糖尿病中药组分配伍优化
作者单位
张美珍1,郝晓晖1,李晓文1,杨亚男1,李艳杰2,刘旭菲1,倪青1 1 中国中医科学院广安门医院北京,100053 2 北京中医药大学研究生院北京100029 
摘要点击次数: 70
全文下载次数: 0
中文摘要:
      目的:系统评价益气活血通络法治疗糖尿病周围神经病变的有效性。方法:检索CNKI、万方、VIP、CBM、Cochrane library、EMbase、PubMed、ClinicalTrails.gov等数据库,查找所有比较益气活血通络中药或联合西药治疗糖尿病周围神经病变的随机对照试验。利用RevMan 5.3软件进行统计分析、Risk of Bias(ROB)表进行质量评价。结果:共纳入23篇随机对照试验,包括1 608例患者。纳入文献的方法学质量较低。采用益气活血通络法治疗糖尿病周围神经病变,能够明显提高临床总有效率(RR=0.30,95%CI为0.24~0.36,P<0.000 01)和降低Toronto积分(MD=-1.35,95%CI为-1.57~-1.13,P<0.000 01),可显著提高正中神经MCV(MD=3.45,95%CI为2.45~4.45,P<0.000 01)、SCV(MD=3.27,95%CI为2.10~4.44,P<0.000 01)和腓总神经MCV(MD=2.99,95%CI为2.00~3.98,P<0.000 01)、SCV(MD=3.43,95%CI为2.02~4.84,P<0.000 01)的传导速度,降低全血高切度(MD=-0.72,95%CI为-0.98~-0.46,P<0.000 01)和低切度(MD=-1.52,95%CI为-2.82~-0.21,P=0.02)水平。观察组治愈时间优于对照组(RR=1.71,95%CI为1.49~1.97,P<0.000 01),差异有统计学意义。23篇RCTs中19篇研究明确无不良反应发生,4项研究说明有不良反应发生,无严重不良事件发生。结论:益气活血通络法治疗糖尿病周围神经病变,可提高疗效,降低Toronto积分,改善代谢紊乱症状和血流变。因纳入研究的文献质量较低,影响疗效的可靠性,今后还需高质量的随机对照试验加以证实。
English Summary:
      To systematically assess the efficacy of enriching qi,promoting blood circulation and dredging meridians therapy for treating diabetic peripheral neuropathy.Methods:A total of 8 databases(CNKI,Wanfang,VIP,CBM,Cochrane Library,EMBASE,PubMed ClinicalTrails.gov)were searched to identify all published randomized controlled trials of enriching qi,promoting blood circulation and dredging meridians herbs combined with western medicine for the treatment of diabetic peripheral neuropathy.The Revman 5.3 software was used for statistical analysis,and the risk of bias(ROB)table was used for quality evaluation.Results:A total of 23 RCTs were identified,including 1608 patients.The methodological quality of the included studies was low.Using activating qi,promoting blood circulation and dredging meridians therapy to treat diabetic peripheral neuropathy can significantly increase the total clinical efficacy [RR=0.30,95%CI(0.24~0.36),reduce the Toronto score [MD=-1.35,95%CI(-1.57~-1.13),P<0.000 01],raise motor nerve conduction velocity of median nerve [MD=3.45,95%CI(2.45~4.45),P<0.000 01] and common peroneal nerve [MD=2.99,95%CI(2.00~3.98),P<0.000 01],and sense nerve conduction velocity of median nerve [MD=3.27,95%CI(2.10~4.44),P<0.000 01],and common peroneal nerve [MD=3.43,95%CI(2.02~4.84),P<0.000 01].The Meta-analysis indicated that the therapy can lower the level of high shear rate of whole blood [MD=-0.72,95%CI(-0.98~-0.46)P<0.000 01],and Whole blood low cut [MD=-1.52,95%CI(-2.82~-0.21),P=0.02].The cure time of the treatment group was better than that of the control group[RR=1.71,95%CI(1.49~1.97),P<0.000 01].A total of 19 studies clearly showed no adverse reactions among the 23 RCTs,4 studies showed adverse reactions.However,no serious adverse events occurred in all studies.Conclusion:Enriching qi,promoting blood circulation and dredging meridians therapy in the treatment of diabetic peripheral neuropathy can improve the efficacy,reduce the Toronto score,improve the symptoms of metabolic disorders and hemorheology.Due to the quality of included studies is low,which affects the reliability of efficacy,high-quality RCTs are needed to confirm such conclusion in the future.
查看全文  查看/发表评论  下载PDF阅读器